SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 61 filers reported holding SYNERON MEDICAL LTD in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,313,000 | -60.6% | 183,382 | -57.7% | 0.04% | -64.5% |
| Q2 2016 | $3,333,000 | -30.4% | 433,382 | -33.9% | 0.12% | -30.5% |
| Q1 2016 | $4,790,000 | -25.5% | 655,265 | -21.5% | 0.17% | -21.3% |
| Q4 2015 | $6,433,000 | -15.9% | 834,324 | -22.0% | 0.22% | -6.8% |
| Q3 2015 | $7,652,000 | -17.1% | 1,070,255 | +23.1% | 0.24% | -9.2% |
| Q2 2015 | $9,232,000 | -14.7% | 869,273 | -0.5% | 0.26% | -15.8% |
| Q1 2015 | $10,817,000 | +33.1% | 873,723 | +0.3% | 0.31% | +30.8% |
| Q4 2014 | $8,130,000 | -8.7% | 871,375 | -1.9% | 0.24% | -13.8% |
| Q3 2014 | $8,901,000 | -3.1% | 888,347 | -0.2% | 0.28% | +2.6% |
| Q2 2014 | $9,182,000 | -20.4% | 889,705 | -4.0% | 0.27% | -13.8% |
| Q1 2014 | $11,539,000 | +10.5% | 926,864 | +9.2% | 0.31% | +16.0% |
| Q4 2013 | $10,440,000 | +55.4% | 848,804 | +9.0% | 0.27% | +50.6% |
| Q3 2013 | $6,716,000 | +2.5% | 779,074 | +3.5% | 0.18% | -5.3% |
| Q2 2013 | $6,550,000 | – | 752,824 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $31,650,000 | 4.86% |
| Discovery Group I, LLC | 1,221,310 | $12,885,000 | 4.30% |
| Kenmare Capital Partners, L.L.C. | 389,177 | $4,106,000 | 3.98% |
| Profit Investment Management, LLC | 237,217 | $2,503,000 | 2.03% |
| Senvest Management, LLC | 2,202,272 | $23,234,000 | 1.66% |
| PERRITT CAPITAL MANAGEMENT INC | 426,370 | $4,498,000 | 1.14% |
| Camber Capital Management LP | 2,347,593 | $24,767,000 | 1.00% |
| DALTON GREINER HARTMAN MAHER & CO | 1,645,048 | $17,355,000 | 0.99% |
| Lapides Asset Management, LLC | 396,800 | $4,186,000 | 0.78% |
| DAFNA Capital Management LLC | 85,947 | $907,000 | 0.77% |